Tempest Therapeutics Statistics
Share Statistics
Tempest Therapeutics has 43.64M shares outstanding. The number of shares has increased by 96.66% in one year.
| Shares Outstanding | 43.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 73.13% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 39.62M |
| Failed to Deliver (FTD) Shares | 9.80K |
| FTD / Avg. Volume | 0.25% |
Short Selling Information
The latest short interest is 2.64M, so 6.04% of the outstanding shares have been sold short.
| Short Interest | 2.64M |
| Short % of Shares Out | 6.04% |
| Short % of Float | 6.66% |
| Short Ratio (days to cover) | 0.39 |
Valuation Ratios
The PE ratio is -2.3 and the forward PE ratio is -0.72.
| PE Ratio | -2.3 |
| Forward PE | -0.72 |
| PS Ratio | 0 |
| Forward PS | 2.3 |
| PB Ratio | 2.53 |
| P/FCF Ratio | -2.46 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tempest Therapeutics Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.29, with a Debt / Equity ratio of 0.39.
| Current Ratio | 4.29 |
| Quick Ratio | 4.29 |
| Debt / Equity | 0.39 |
| Total Debt / Capitalization | 28.27 |
| Cash Flow / Debt | -2.59 |
| Interest Coverage | -20.12 |
Financial Efficiency
Return on equity (ROE) is -1.1% and return on capital (ROIC) is -61.48%.
| Return on Equity (ROE) | -1.1% |
| Return on Assets (ROA) | -0.57% |
| Return on Capital (ROIC) | -61.48% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.73M |
| Employee Count | 17 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -77.2% in the last 52 weeks. The beta is -2.78, so Tempest Therapeutics 's price volatility has been lower than the market average.
| Beta | -2.78 |
| 52-Week Price Change | -77.2% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 2.01 |
| Relative Strength Index (RSI) | 59.5 |
| Average Volume (20 Days) | 3.86M |
Income Statement
| Revenue | n/a |
| Gross Profit | -381.00K |
| Operating Income | -29.16M |
| Net Income | -29.49M |
| EBITDA | -28.78M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.91 |
Balance Sheet
The company has 39.23M in cash and 20.66M in debt, giving a net cash position of 18.57M.
| Cash & Cash Equivalents | 39.23M |
| Total Debt | 20.66M |
| Net Cash | 18.57M |
| Retained Earnings | -165.26M |
| Total Assets | 33.84M |
| Working Capital | 9.58M |
Cash Flow
In the last 12 months, operating cash flow was -27.36M and capital expenditures -170.00K, giving a free cash flow of -27.53M.
| Operating Cash Flow | -27.36M |
| Capital Expenditures | -170.00K |
| Free Cash Flow | -27.53M |
| FCF Per Share | -1.79 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -198.96% |
| FCF Yield | -66.01% |
Analyst Forecast
The average price target for TPST is $13, which is 1254.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $13 |
| Price Target Difference | 1254.2% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jun 28, 2021. It was a backward split with a ratio of 1:15.
| Last Split Date | Jun 28, 2021 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -9.98 |
| Piotroski F-Score | 3 |